Analyst Michael Diana of Maxim Group reiterated a Buy rating on PaySign (PAYS – Research Report), with a price target of $7.00.
Michael Diana has given his Buy rating due to a combination of factors including PaySign’s strong financial performance and growth prospects. The company’s fourth-quarter results exceeded expectations in terms of revenue and adjusted EBITDA, driven largely by the expansion of pharma patient affordability programs, which have higher gross margins compared to other segments.
Looking forward, PaySign’s initial guidance for 2025 aligns with expectations, with significant revenue and EBITDA growth anticipated. The company has already added several new pharma programs in the first quarter of 2025, indicating a robust pipeline for future growth. Additionally, PaySign’s solid balance sheet, characterized by substantial cash reserves and no debt, further supports its growth trajectory without the need for additional capital. These factors collectively underpin the Buy rating and the maintained price target of $7.00, suggesting a potential return of over 200% as the stock price appreciates.
Diana covers the Financial sector, focusing on stocks such as Cullen/Frost Bankers, First Savings Financial Group, and Horizon Technology. According to TipRanks, Diana has an average return of 3.7% and a 54.80% success rate on recommended stocks.
In another report released yesterday, Barrington also maintained a Buy rating on the stock with a $5.00 price target.